What is serotonin syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Serotonin Syndrome?

Serotonin syndrome is a potentially life-threatening toxic condition caused by excessive serotonergic activity in the central nervous system, characterized by a clinical triad of mental status changes, autonomic hyperactivity, and neuromuscular abnormalities. 1, 2

Clinical Presentation

Serotonin syndrome manifests through three distinct categories of symptoms that occur together:

Mental Status Changes

  • Patients present with agitated delirium, confusion, or altered consciousness ranging from mild confusion to coma in severe cases 2
  • These changes develop rapidly, typically within 6-24 hours after starting or increasing a serotonergic medication 1, 2

Autonomic Hyperactivity

  • Hyperthermia (elevated temperature up to 41.1°C) 2
  • Tachycardia and tachypnea 2
  • Hypertension or blood pressure fluctuations (≥20 mm Hg diastolic or ≥25 mm Hg systolic change within 24 hours) 2
  • Diaphoresis and mydriasis 2

Neuromuscular Abnormalities

  • Clonus (spontaneous, inducible, or ocular) and hyperreflexia are highly diagnostic features when occurring with serotonergic drug use 1, 2
  • Myoclonus (present in 57% of cases) 3
  • Muscle rigidity and tremor 2

Diagnostic Criteria

The American Academy of Pediatrics recommends using the Hunter Criteria for diagnosis, which requires the presence of a serotonergic agent plus one of the following 1, 2:

  • Spontaneous clonus
  • Inducible clonus with agitation or diaphoresis
  • Ocular clonus with agitation or diaphoresis
  • Tremor and hyperreflexia
  • Hypertonia with temperature above 38°C and ocular or inducible clonus

There are no pathognomonic laboratory or radiographic findings for serotonin syndrome—diagnosis is purely clinical 2

Severity and Prognosis

Severity Classification

  • Mild cases: May be easily missed due to variable presentation 2
  • Moderate cases: Require hospitalization with continuous cardiac monitoring 1
  • Severe cases: Medical emergency with rapid onset of severe hyperthermia (>41.1°C), muscle rigidity, and multiple organ failure 2

Mortality and Complications

  • The mortality rate is approximately 11% 1, 2
  • Approximately one-quarter of patients require intubation, mechanical ventilation, and ICU admission 1
  • Complications include rhabdomyolysis with elevated creatine kinase, metabolic acidosis, elevated serum aminotransferase, renal failure, seizures, and disseminated intravascular coagulopathy 2

Causative Mechanisms

  • Serotonin syndrome is non-idiosyncratic, meaning it is predictable and occurs with the addition of a new serotonergic drug, increased dosage of an existing drug, or addition of a second serotonergic agent 2, 3
  • It results from excessive stimulation of central nervous system 5-HT1A and 5-HT2A receptors 4
  • Can occur with a single standard therapeutic dose, drug interactions, excessive use, or intentional overdose 5

Important Diagnostic Pitfalls

Serotonin syndrome can be confused with several other conditions 1, 3:

  • Neuroleptic malignant syndrome
  • Malignant hyperthermia
  • Anticholinergic syndrome
  • Withdrawal syndromes
  • Sepsis 6
  • Decompensated hyperthyroidism 6

The key differentiating features are myoclonus and hyperreflexia, which are characteristic of serotonin syndrome 3

References

Guideline

Management of Serotonin Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Serotonin Syndrome Diagnosis and Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Serotonin Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of the serotonin syndrome with cyproheptadine.

The Journal of emergency medicine, 1998

Research

Overview of serotonin syndrome.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2012

Research

High risk and low prevalence diseases: Serotonin syndrome.

The American journal of emergency medicine, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.